ACE up the sleeve - are vascular patients medically optimized?

Hdl Handle:
http://hdl.handle.net/10147/135094
Title:
ACE up the sleeve - are vascular patients medically optimized?
Authors:
Coveney, A P; O'Brien, G C; Fulton, G J
Affiliation:
Department of Vascular Surgery, Cork University Hospital, National University of Ireland, Cork, Ireland. acoveney@gmail.com
Citation:
ACE up the sleeve - are vascular patients medically optimized? 2011, 7:15-21 Vasc Health Risk Manag
Journal:
Vascular health and risk management
Issue Date:
Mar-2011
URI:
http://hdl.handle.net/10147/135094
DOI:
10.2147/VHRM.S15484
PubMed ID:
21339909
Additional Links:
http://www.ncbi.nlm.nih.gov/pubmed/21339909
Abstract:
To examine the current medical management of arteriopathic patients attending a vascular surgical service at a university teaching hospital over a 6-month period. The prescribing of antiplatelets, statins, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers and beta-blockers was specifically examined. Vascular patients are often under the care of multiple specialties, and therefore the influence of different medical specialties on the patients' medical management was also examined.; Between January and June 2009, data were recorded on sequential patients with arterial disease attending the vascular surgical service. Patients' demographics, type of arterial disease, medical consultations within the previous 12 months, and current medications were recorded.; The study included 180 patients with a mean age of 69 years (39-88 years). All but 4% were taking an antiplatelet or anticoagulant, predominantly aspirin. There were 86% taking a statin, 44% taking a beta-blocker, and 51% taking an ACE inhibitor. Suboptimal prescription of ACE inhibitors and beta-blockers was evident regardless of the type of medical consultations in the previous year. No specialty group differed significantly from vascular surgeons in their prescribing pattern.; While almost all arteriopaths receive some form of antiplatelet and statin in line with clinical evidence, ACE inhibitors and beta-blockers appear to be under-prescribed in this arteriopathic population. We conclude that opportunity exists for vascular surgeons to embrace recent guidelines and lead the way in both surgical and medical optimization of arteriopathic patients through improving links with primary care physicians or taking greater responsibility themselves for the medical as well as the surgical care of their arteriopathic patients.
Item Type:
Article
Language:
en
MeSH:
Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Drug Therapy, Combination; Drug Utilization; Female; Guideline Adherence; Hospitals, University; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ireland; Male; Middle Aged; Outpatient Clinics, Hospital; Peripheral Arterial Disease; Physician's Practice Patterns; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prospective Studies; Referral and Consultation; Vascular Surgical Procedures
ISSN:
1178-2048

Full metadata record

DC FieldValue Language
dc.contributor.authorCoveney, A Pen
dc.contributor.authorO'Brien, G Cen
dc.contributor.authorFulton, G Jen
dc.date.accessioned2011-07-01T11:35:12Z-
dc.date.available2011-07-01T11:35:12Z-
dc.date.issued2011-03-
dc.identifier.citationACE up the sleeve - are vascular patients medically optimized? 2011, 7:15-21 Vasc Health Risk Managen
dc.identifier.issn1178-2048-
dc.identifier.pmid21339909-
dc.identifier.doi10.2147/VHRM.S15484-
dc.identifier.urihttp://hdl.handle.net/10147/135094-
dc.description.abstractTo examine the current medical management of arteriopathic patients attending a vascular surgical service at a university teaching hospital over a 6-month period. The prescribing of antiplatelets, statins, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers and beta-blockers was specifically examined. Vascular patients are often under the care of multiple specialties, and therefore the influence of different medical specialties on the patients' medical management was also examined.-
dc.description.abstractBetween January and June 2009, data were recorded on sequential patients with arterial disease attending the vascular surgical service. Patients' demographics, type of arterial disease, medical consultations within the previous 12 months, and current medications were recorded.-
dc.description.abstractThe study included 180 patients with a mean age of 69 years (39-88 years). All but 4% were taking an antiplatelet or anticoagulant, predominantly aspirin. There were 86% taking a statin, 44% taking a beta-blocker, and 51% taking an ACE inhibitor. Suboptimal prescription of ACE inhibitors and beta-blockers was evident regardless of the type of medical consultations in the previous year. No specialty group differed significantly from vascular surgeons in their prescribing pattern.-
dc.description.abstractWhile almost all arteriopaths receive some form of antiplatelet and statin in line with clinical evidence, ACE inhibitors and beta-blockers appear to be under-prescribed in this arteriopathic population. We conclude that opportunity exists for vascular surgeons to embrace recent guidelines and lead the way in both surgical and medical optimization of arteriopathic patients through improving links with primary care physicians or taking greater responsibility themselves for the medical as well as the surgical care of their arteriopathic patients.-
dc.language.isoenen
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/21339909en
dc.subject.meshAdrenergic beta-Antagonists-
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAngiotensin II Type 1 Receptor Blockers-
dc.subject.meshAngiotensin-Converting Enzyme Inhibitors-
dc.subject.meshCardiovascular Agents-
dc.subject.meshDrug Therapy, Combination-
dc.subject.meshDrug Utilization-
dc.subject.meshFemale-
dc.subject.meshGuideline Adherence-
dc.subject.meshHospitals, University-
dc.subject.meshHumans-
dc.subject.meshHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subject.meshIreland-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshOutpatient Clinics, Hospital-
dc.subject.meshPeripheral Arterial Disease-
dc.subject.meshPhysician's Practice Patterns-
dc.subject.meshPlatelet Aggregation Inhibitors-
dc.subject.meshPractice Guidelines as Topic-
dc.subject.meshProspective Studies-
dc.subject.meshReferral and Consultation-
dc.subject.meshVascular Surgical Procedures-
dc.titleACE up the sleeve - are vascular patients medically optimized?en
dc.typeArticleen
dc.contributor.departmentDepartment of Vascular Surgery, Cork University Hospital, National University of Ireland, Cork, Ireland. acoveney@gmail.comen
dc.identifier.journalVascular health and risk managementen
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.